 |
Turna Ray is the editor of GenomeWeb's Pharmacogenomics Reporter. She covers pharmacogenomics, personalized medicine, and companion diagnostics. E-mail Turna Ray or follow her GenomeWeb Twitter account at @PGxReporter. |
New Studies Suggest Crescendo's Vectra DA Can Track Rheumatoid Arthritis in Variety of Settings
December 12, 2012
New Studies Suggest Crescendo's Vectra DA Can Track Rheumatoid Arthritis in Variety of Settings
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Crescendo Aims for 'Full Launch Velocity' for Vectra DA, Focus on Educating RA Patients in 2013
January 9, 2013 / Pharmacogenomics Reporter - Data Suggests Crescendo Test Tracks Rheumatoid Arthritis Patients' Response to Anti-TNF Therapies
November 9, 2011 / Pharmacogenomics Reporter - New York Clears Crescendo Bio to Offer RA Test
April 18, 2013 / GenomeWeb Daily News - Crescendo Bioscience Raises $28M in Series D Financing Round
January 3, 2013 / GenomeWeb Daily News - Crescendo Publishes Validation Study Supporting Use of Vectra DA for Assessing RA Activity
July 6, 2012 / ProteoMonitor